The peer-review journal The Lancet HIV recently published the results of an extensive study by vaccine experts that concluded HIV patients must be included in clinical trials for new tuberculosis (TB) vaccine candidates currently in development.
And ensure people living with HIV have access to safe and effective TB vaccines, similar to the general population.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
